1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Opportunity in the Indian Pharmaceutical Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

This report provides an insight into the Indian Pharmaceutical current market scenario, structure and practices.

In depth market scenario includes;
- Current market size estimates, including domestic market, imports and exports
- Market size by product categories - Bulk drugs, Formulations
- Market size by players - Top Companies
- Market size by player categories - Large (More Than INR 1000 Crores), Medium (INR 500-1000 Crores), Small (Less Than INR 500 Crores)
- Market size by domestic manufacturing vs. exports
- Past performance of top 10 companies

Market structure details the player categories, key players’ presence across products. Market practices include understanding the Indian Pharmaceutical business, market trends and distribution practices.

The report also provides a snapshot of key competition, past market trends with forecast over the next 5 years, anticipated growth rates and the principal factors driving and impacting growth

Market data and analytics are derived from a combination of primary and secondary sources

Table Of Contents

Opportunity in the Indian Pharmaceutical Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast
Section 1: Background
Scope of this research
Research aim and objectives
Research methodology

Section 2: Executive Summary
Market landscape
Future opportunity

Section 3: Market Overview
Market value chain
Key activities and evolution of Indian Pharmaceutical market
FDI inflow
Market structure (player categorization)
Player wise presence by product categories
Key market trends
Distribution structure

Section 4: Estimate of Market Size in India
All India market size (volume) - Domestic, Exports, Imports
All India market size (value) - Domestic, Exports, Imports
Past 3 years market growth

Section 5: Market Share Estimates
Market size by product categories
Market size by players
Market size by player categories
Market size by domestic manufacturing vs. exports
Past performance of top 10 companies

Section 6: Factors Impacting Market Growth
Market drivers
Market challenges
Market restraints

Section 7: Market Forecast
Overall market forecast - FY 12 to FY 17
5 years market forecast by product categories

Section 8: Snapshot of Top 3 Players
Abbott India Ltd
Ranbaxy
Dr. Reddy's Laboratories
Lupin Ltd
Aurobindo Pharma
Dabur
Sun Pharmaceutical
Cadila Healthcare
Jubliant Lifescience
Piramal Healthcare

Section 9: About Us

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.